DR.NOAH BIOTECH

Under a ‘pilot project to build bio-big data for all ministries,' promoted by three ministries including the Ministry of Science and ICT, big data on genomic information, such as rare diseases, of 20,000 people is being established. With this, there is a growing interest in developing medicines for rare diseases. Dr. Noa Biotech, a drug development company that uses AI technology, continues to develop new drugs with focus on rare disease treatment through its own platform... Owing to that, DR. NOAH BIOTECH is currently divided into Research Center and Development Center. The Research Center is composed of ▲Data Management Team, in charge of the whole dielectric substances and chemical compounds used for artificial intelligence; and the management of internal experiment results and literature data, ▲Data Analysis Team in charge of drug predictions and the development of all analytical software of the artificial intelligence on the ARK platform developed by the company and ▲Validation..

Also known as: Dr. Noa Biotech